Aclarion, Inc.
For the period ended Mar 31, 2025. Filed May 15, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 15, 2025
ACON$1.60-8.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Statements of Cash Flows
(unaudited)
| Three Months Ended March 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Cash flows from operating activities | ||
| Net loss | $(2,037,436) | $(2,399,102) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization | 55,167 | 45,109 |
| Share-based compensation | 55,897 | 85,827 |
| Loss on exchange of debt | – | 1,066,732 |
| Loss on extinguishment of debt | – | 111,928 |
| Amortization of deferred issuance costs | – | 335,352 |
| Change in fair value related to warrants and derivative | (11,721) | (297,684) |
| Non-cash settlements | 58,272 | – |
| Amendment of warrants | 48,087 | – |
| Change in assets and liabilities | ||
| Accounts receivable | (849) | (2,616) |
| Prepaids and other current assets | (40,841) | (134,760) |
| Accounts payable | (15,334) | (640,163) |
| Accrued and other liabilities | (622,024) | (409,180) |
| Net cash (used in) operations | (2,510,782) | (2,238,557) |
| Investing activities | ||
| Intangible assets - Patents | (78,288) | (63,657) |
| Net cash (used in) investing activities | (78,288) | (63,657) |
| Financing activities | ||
| Public offering of common stock and warrants | 14,554,545 | 3,001,496 |
| Common stock cash issuance costs | (1,959,642) | (712,899) |
| Registered Direct offerings | 5,167,927 | – |
| Exercise of Series C warrants | 336,441 | – |
| Redemption of Series B preferred stock | (1,213,590) | – |
| Proceeds from equity line | – | 1,449,532 |
| Repayment of promissory notes | – | (300,974) |
| Bridge fund cash issuance costs | – | (23,375) |
| Net cash provided by financing activities | 16,885,681 | 3,413,780 |
| Net increase (decrease) in cash and cash equivalents | 14,296,611 | 1,111,566 |
| Cash, cash equivalents and restricted cash, beginning of period | 463,661 | 1,031,069 |
| Cash, cash equivalents and restricted cash, end of period | $14,760,272 | $2,142,635 |
| Non-cash activities | ||
| Capitalization of B-Series preferred stock dividends | 5,425 | – |
| Capitalization of Series C preferred stock dividends | 1,258 | – |
| Conversion of Series C preferred stock to common stock | 548,534 | – |
| Cashless exercise of B warrants to common stock | 9,539,081 | – |
| Issuance of common shares in exchange for debt | – | 1,771,606 |
| Issuance of bridge fund commitment shares | – | 33,297 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.